Open AccessMissing the benefit of metformin in acute myeloid leukemia: A problem of contrast?
Author(s) -
Alice C. Ceacareanu,
George K. Nimako,
Zachary A.P. Wintrob
Publication year - 2017
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/jrpp.jrpp_17_37
Subject(s) - medicine , metformin , hazard ratio , proportional hazards model , myeloid leukemia , oncology , diabetes mellitus , cancer , confidence interval , insulin , endocrinology
To evaluate whether metformin's cancer-related benefits reported in patients with solid tumors (ST) are also present in acute myeloid leukemia (AML) patients.